Relationship of p53 and vascular endothelial growth factor expression to clinicopathological factors in human scirrhous gastric cancer

European Surgical Research

Volumn 30, Issue 2, 1998, Pages 130-137

  Baba, M ^a   Konno, H ^a   Maruo, Y ^a   Tanaka, T ^a   Kanai, T ^a   Matsumoto, K ^a   Matsuura, M ^a   Nishino, N ^a   Maruyama, K ^a   Nakamura, S ^a   Baba, S ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

p53; Scirrhous gastric cancer; Vascular endothelial growth factor

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROSA; STOMACH CANCER;

ADENOCARCINOMA, SCIRRHOUS; ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 6844259862     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008568     Document Type: Article

References (28)

1. Tahara E: Molecular biology of gastric cancer. World J Surg 1995;19: 484-490.
2. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-272.
3. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
4. Bicknell R, Harris AL: Novel growth regulatory factors and tumor angiogenesis. EurJ Cancer 1991;27:781-784.
5. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
6. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-374.
7. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y, Sowa M: Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72:319-323.
8. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
9. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161: 851-858.
10. Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85: 1045-1049.
11. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
12. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-3968.
13. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-863.
14. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181: 902-906.
15. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF: Vascular permeability factor (VPF, VEGF) in tumor biology Cancer Metastasis Rev 1993;12: 303-324.
16. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K: Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 1993;67:589-593.
17. Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;66:558-562.
18. Mukhopadhyay D, Tsiokas L, Sukhatme VP: Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55:6161-6165.
19. Japanese Research Society for Gastric Cancer: The general rules for gastric cancer study, ed 12 (in Japanese). Tokyo, Kanehara, 1993.
20. Ranzani GN, Luinetti O, Padovan LS, Calstri D, Renault B, Burrel M, Amadori D, Fiocca R, Solcia E: p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 1995;4: 223-231.
21. Oiwa H, Maehara Y, Ohno S, Sakaguchi Y, Ichiyoshi Y, Sugimachi K: Growth pattern and p53 overexpression in patients with early gastric cancer. Cancer 1995;75:1454-1459.
22. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995;270:9709-9716.
23. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazaki T, Kerbel RS: Mutant ras oncogenes up-regulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575-4580.
24. Mukhopadhyay D, Tsiokas L, Zhou X, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995;375:577-581.
25. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marme D: Both v-H-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 1995;270:25915-25919.
26. Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ: Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res 1996;56:3436-3440.
27. Keiser A, Weich HA, Brandner G, Marme D, Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994;9: 963-969.
28. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M: Establishment of two new scirrhous gastric cancer cell lines: Analysis of factors associated with disseminated metastasis. Br J Cancer 1995;72:1200-1210.